Title : A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

Pub. Date : 2009 Jul 1

PMID : 19398921






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CD4 counts and plasma lipids showed higher increments in the abacavir/lamivudine group than in the tenofovir/emtricitabine group. Tenofovir CD4 molecule Homo sapiens